TrialDiabetes, obesity & metabolism2026

Impact of iGlarLixi on Glycaemic Control Depth and Variability in Asian Pacific People With Type 2 Diabetes: A Post Hoc Analysis of LixiLan-O-AP and LixiLan-L-CN.

Jiaying Ni et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.